|
Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial. |
|
|
Leadership - PFS Genomics |
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; PFS Genomics; SerImmune |
|
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; EMD Serono; Genzyme; Janssen Biotech; Medivation/Astellas |
Research Funding - Zenith Epigenetics |
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst) |
|
|
Stock and Other Ownership Interests - Radiogel |
Consulting or Advisory Role - Janssen |
Other Relationship - Caribou Publishing |
|
|
Employment - Decipher Biosciences |
|
|
Stock and Other Ownership Interests - 3D Biopsy; 3Scan; Abbvie; Lightspeed Microscopy |
Research Funding - GenomeDx; Genomic Health; Progenetics |
|
|
Employment - Decipher Biosciences |
Leadership - Decipher Biosciences |
Stock and Other Ownership Interests - Decipher Biosciences |
Patents, Royalties, Other Intellectual Property - Decipher Biosciences |
|
|
Stock and Other Ownership Interests - Augmenix; Volatilyx (I) |
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Nanobiotix |
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I) |
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I) |
Travel, Accommodations, Expenses - Ferring |
|
|
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Janssen; Taris BioMedical |
|
|
Leadership - American Society for Radiation Oncology; Department of Defense-Prostate Cancer Research Program; NRG Oncology |
Stock and Other Ownership Interests - Oncohost |
Consulting or Advisory Role - Apex; Celldex; Cybrexa Therapeutics; EMD Serono; Janssen; Johnson & Johnson; Oncohost; Roche; Self Care Catalysts; Third Bridge |
Research Funding - Prostate Cancer Foundation |
Patents, Royalties, Other Intellectual Property - We recently filed a patient "DOPED BEO COMPOUNDS FOR OPTICALLY STIMULATED LUMINESCENCE (OSL) AND THERMOLUMINESCENCE (TL) RADIATION DOSIMETRY" |
Expert Testimony - Wilson Sonsini |
Travel, Accommodations, Expenses - EMD Serono; Ferring; Merck KGaA; Self Care Catalysts |
Other Relationship - Dreamit Ventures |
|
|
Consulting or Advisory Role - Merck |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Millennium (Inst); Pfizer (Inst) |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen Oncology |
|
|
No Relationships to Disclose |
|
|
Honoraria - Reflexion Medical |
Consulting or Advisory Role - Astellas Pharma; Dendreon; GenomeDx; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron |
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst) |
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471. |
Travel, Accommodations, Expenses - Reflexion Medical |